Significance of HPV16 Viral Load Testing in Anal Cancer

[1]  Jongseung Kim,et al.  Type-Specific Viral Load and Physical State of HPV Type 16, 18, and 58 as Diagnostic Biomarkers for High-Grade Squamous Intraepithelial Lesions or Cervical Cancer , 2019, Cancer research and treatment : official journal of Korean Cancer Association.

[2]  Chunlian Liu,et al.  Association of estradiol and HPV/HPV16 infection with the occurrence of cervical squamous cell carcinoma. , 2019, Oncology letters.

[3]  T. Rutkowski,et al.  Detection of circulating HPV16 DNA as a biomarker in the blood of patients with human papillomavirus‐positive oropharyngeal squamous cell carcinoma , 2019, Head & neck.

[4]  B. Sorbe,et al.  HPV16 viral characteristics in primary, recurrent and metastatic vulvar carcinoma , 2018, Papillomavirus research.

[5]  O. Mariani,et al.  Array comparative genomic hybridization identifies high level of PI3K/Akt/mTOR pathway alterations in anal cancer recurrences , 2018, Cancer medicine.

[6]  Wenjing Zhang,et al.  Dynamics of HPV viral loads reflect the treatment effect of photodynamic therapy in genital warts. , 2018, Photodiagnosis and photodynamic therapy.

[7]  M. Martinelli,et al.  Human papillomavirus DNA detection in plasma and cervical samples of women with a recent history of low grade or precancerous cervical dysplasia , 2017, PloS one.

[8]  A. Kowalczyk,et al.  Differences in the prognosis of HPV16-positive patients with squamous cell carcinoma of head and neck according to viral load and expression of P16 , 2017, Journal of Cancer Research and Clinical Oncology.

[9]  N. Wentzensen,et al.  Somatic Host Cell Alterations in HPV Carcinogenesis , 2017, Viruses.

[10]  M. von Knebel Doeberitz,et al.  Diagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: A systematic review and meta‐analysis , 2017, International journal of cancer.

[11]  G. Getz,et al.  Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma , 2016, Clinical Cancer Research.

[12]  James X. Sun,et al.  Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  R. Yelensky,et al.  Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing. , 2015 .

[14]  J. Beijnen,et al.  HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53 , 2015, British Journal of Cancer.

[15]  R. Wirtz,et al.  Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy , 2015, International journal of cancer.

[16]  Yoshihiko Maehara,et al.  Discrimination of p53 immunohistochemistry-positive tumors by its staining pattern in gastric cancer , 2014, Cancer medicine.

[17]  M. Ozbun,et al.  Tobacco exposure results in increased E6 and E7 oncogene expression, DNA damage and mutation rates in cells maintaining episomal human papillomavirus 16 genomes. , 2014, Carcinogenesis.

[18]  Jeong Hwan Park,et al.  High‐risk human papillomavirus load and biomarkers in cervical intraepithelial neoplasia and cancer , 2014, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[19]  Nikhil Wagle,et al.  Oncogenic mutations in cervical cancer , 2013, Cancer.

[20]  E. Sturgis,et al.  Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma. , 2012, Seminars in radiation oncology.

[21]  W. Westra,et al.  Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus‐associated head and neck cancer based on a prospective clinical experience , 2010, Cancer.

[22]  A. Venuti,et al.  Persistence of HPV after radio-chemotherapy in locally advanced cervical cancer. , 2010, Oncology reports.

[23]  M. Schiffman,et al.  Relationship Between Cigarette Smoking and Human Papilloma Virus Types 16 and 18 DNA Load , 2009, Cancer Epidemiology, Biomarkers & Prevention.

[24]  Martin Görner,et al.  HPV & head and neck cancer: a descriptive update , 2009, Head & neck oncology.

[25]  R. Chatterjee,et al.  HPV viral load determination during pregnancy as a possible cervical cancer risk. , 2006, Journal of experimental & clinical cancer research : CR.

[26]  B. Morris.  Cervical human papillomavirus screening by PCR: advantages of targeting the E6/E7 region , 2005, Clinical chemistry and laboratory medicine.

[27]  N. Muñoz,et al.  Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking. , 2003, Journal of the National Cancer Institute. Monographs.

[28]  A. Walch,et al.  Staining patterns of p53 immunohistochemistry and their biological significance in colorectal cancer , 2000, The Journal of pathology.

[29]  H. Bradlow,et al.  Estrogen Metabolism and the Malignant Potential of Human Papillomavirus Immortalized Keratinocytes , 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[30]  N. Park,et al.  Combined oral carcinogenicity of HPV-16 and benzo(a)pyrene: an in vitro multistep carcinogenesis model. , 1995, Oncogene.

[31]  C. Woodworth,et al.  The interaction between HPV infection and estrogen metabolism in cervical carcinogenesis , 1991, International journal of cancer.

[32]  L. Brinton,et al.  Biochemical epidemiology of cervical neoplasia: measuring cigarette smoke constituents in the cervix. , 1987, Cancer research.